Xinxia Li

695 total citations
52 papers, 460 citations indexed

About

Xinxia Li is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xinxia Li has authored 52 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Xinxia Li's work include Lymphoma Diagnosis and Treatment (18 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Xinxia Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). Xinxia Li collaborates with scholars based in China, United States and Montenegro. Xinxia Li's co-authors include Wenli Cui, Chaobo Huang, Qian Zhang, Fang Wang, Wei Shao, Kexin Huang, Michael A. McNutt, Wei Zhang, Jiang Gu and Virginia Anderson and has published in prestigious journals such as Carbohydrate Polymers, Frontiers in Immunology and Food Hydrocolloids.

In The Last Decade

Xinxia Li

49 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxia Li China 11 118 103 97 70 54 52 460
Haotian Liao China 8 147 1.2× 23 0.2× 119 1.2× 39 0.6× 82 1.5× 15 486
Zhenggui Du China 18 156 1.3× 81 0.8× 187 1.9× 54 0.8× 16 0.3× 64 786
Liu He China 14 99 0.8× 160 1.6× 82 0.8× 31 0.4× 94 1.7× 29 529
Weijia Lu China 6 96 0.8× 31 0.3× 70 0.7× 47 0.7× 64 1.2× 8 332
Shihai Liu China 13 90 0.8× 50 0.5× 249 2.6× 35 0.5× 11 0.2× 35 510
Xiangping Song China 17 228 1.9× 37 0.4× 168 1.7× 53 0.8× 11 0.2× 29 681
Gaowen Chen China 12 76 0.6× 25 0.2× 119 1.2× 46 0.7× 14 0.3× 24 479
Catherine M. Listinsky United States 15 143 1.2× 136 1.3× 230 2.4× 14 0.2× 45 0.8× 35 680
Shino Nakagawa Japan 13 125 1.1× 74 0.7× 107 1.1× 38 0.5× 6 0.1× 27 534
Fang‐Yi Huo China 10 82 0.7× 34 0.3× 142 1.5× 23 0.3× 8 0.1× 14 362

Countries citing papers authored by Xinxia Li

Since Specialization
Citations

This map shows the geographic impact of Xinxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxia Li more than expected).

Fields of papers citing papers by Xinxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxia Li. The network helps show where Xinxia Li may publish in the future.

Co-authorship network of co-authors of Xinxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxia Li. A scholar is included among the top collaborators of Xinxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxia Li. Xinxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinxia, Zhenlin Li, Tao Luo, et al.. (2025). Visceral fat-to-muscle mass ratio to predict cardiovascular events and mortality in patients with chronic obstructive pulmonary disease: A prospective cohort study. Respiratory Medicine. 246. 108215–108215. 1 indexed citations
3.
4.
Wang, Cancan, Ran Zhang, Huan Zhang, et al.. (2024). Lipid metabolism-related gene signature predicts prognosis and unveils novel anti-tumor drugs in specific type of diffuse large B cell lymphoma. Molecular Medicine. 30(1). 210–210. 3 indexed citations
6.
Gao, Hongliang, et al.. (2023). Vitamin D3 alleviates inflammation in ulcerative colitis by activating the VDR-NLRP6 signaling pathway. Frontiers in Immunology. 14. 1135930–1135930. 14 indexed citations
7.
Li, Xinxia, et al.. (2022). Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma. Evidence-based Complementary and Alternative Medicine. 2022. 1–14. 2 indexed citations
8.
Ma, Jiajia, et al.. (2022). Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma. Analytical Cellular Pathology. 2022. 1–13. 5 indexed citations
9.
Chen, Yang, et al.. (2022). hsa-MicroRNA-28-5p Inhibits Diffuse Large B-Cell Lymphoma Cell Proliferation by Downregulating 14-3-3ζ Expression. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 9 indexed citations
10.
Li, Xinxia, et al.. (2022). Assessing Workplace Stress Among Nurses Using Heart Rate Variability Analysis With Wearable ECG Device–A Pilot Study. Frontiers in Public Health. 9. 810577–810577. 16 indexed citations
11.
Yang, Liuqing, et al.. (2022). Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma. Pathology - Research and Practice. 231. 153781–153781. 4 indexed citations
12.
Liu, Bo, Sijing Li, Qian Zhang, et al.. (2022). Correlation study of PD-L1, CD4, CD8, and PD-1 in primary diffuse large B-cell lymphoma of the central nervous system. Pathology - Research and Practice. 239. 154008–154008. 4 indexed citations
13.
Gao, Haixia, Sijing Li, Jing Niu, et al.. (2020). Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma. Current Medical Science. 40(5). 885–899. 6 indexed citations
14.
Niu, Jing, et al.. (2019). Clinical significance of ‘double-hit’ and ‘double-expression’ lymphomas. Journal of Clinical Pathology. 73(3). 126–138. 15 indexed citations
15.
Gao, Haixia, Wenli Cui, Jing Xue, et al.. (2019). Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics. Pathology - Research and Practice. 215(9). 152528–152528. 10 indexed citations
16.
Pang, Xuelian, Qiao‐Xin Li, Yi Shi, et al.. (2017). Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and <em>KRAS</em> mutation. OncoTargets and Therapy. Volume 10. 2645–2654. 8 indexed citations
17.
Cui, Wenli, Shutao Zheng, Xinxia Li, et al.. (2016). PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc. Tumor Biology. 37(9). 12767–12777. 5 indexed citations
18.
Li, Qiao‐Xin, Yuqing Ma, Wenli Cui, et al.. (2014). Five Common Haplotype-Tagging Variants of Adiponectin ( ADIPOQ ) and Cancer Susceptibility: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(6). 417–424. 10 indexed citations
19.
Li, Xinxia, Encong Gong, Michael A. McNutt, et al.. (2007). Assessment of diagnostic accuracy and feasibility of dynamic telepathology in China. Human Pathology. 39(2). 236–242. 27 indexed citations
20.
Chang, Bin, Feng Li, Xinxia Li, et al.. (2003). [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR].. PubMed. 83(15). 1336–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026